INSIGHTS · 5 MIN READ · BY CannaBless Editorial

Thailand OEM Medical-Cannabis Production 2026: The Capital-Light Route for Foreign Brands

How a foreign brand has branded medical cannabis made against a licensed Thai producer via OEM contract manufacturing — no restricted equity, no nominee. What you supply, what the licence-holder holds.

Thailand OEM Medical-Cannabis Production 2026: The Capital-Light Route for Foreign Brands

What OEM means in Thai medical cannabis

Most foreign parties who study Thailand assume the only way in is to own something — a farm, a licence, a slice of a Thai company. That assumption is where a great deal of capital ends up trapped in a structure it cannot enforce.

There is a lighter route that delivers the thing a foreign brand actually wants — branded product in a destination market — without a restricted equity position at all. It is OEM, or contract manufacturing.

In this model you do not buy or run a Thai cannabis business. You commission one. A licensed Thai producer — a farm holding the cultivation and DTAM licence stack — grows and manufactures product to your written specification, under your brand, against a purchase commitment.

You own the specification, the brand, and the offtake relationship into your market. The producer owns the plants, the premises, and every licence. Nobody has to pretend the foreigner controls the Thai entity, because the foreigner does not need to.

This is the same OEM logic that runs cosmetics, supplements and generic pharma across Southeast Asia, applied to a controlled botanical. The regulatory perimeter is stricter, but the commercial shape is familiar: a brand owner and a licensed maker, joined by a contract.

Who supplies what

The division of roles is the whole point, so it is worth stating precisely.

The foreign party supplies:

The licensed Thai producer holds:

Because the licence never leaves Thai hands and you never claim to control it, nothing here touches the foreign-ownership ceiling that shapes a JV or BOI vehicle. You are buying a made-to-order product, lawfully.

Why OEM is capital-light — and where it stops

A JV ties up capital in an operating company and a governance negotiation. A BOI-promoted vehicle is powerful, but takes time to structure and win. OEM sits below both.

Your outlay is a purchase order and a working-capital line, not equity in a Thai company. That lets you test a market, a brand and a cultivar with a single contracted run before committing to a heavier structure.

What OEM does not give you is ownership of the Thai upside. You do not accrue the value of the farm or the licence; you own your brand and your offtake.

For a foreign party whose real goal is supply into a destination market rather than a Thai balance-sheet asset, that trade is usually the right one. OEM can later graduate into a JV or a BOI application once the commercial case is proven.

The line you must not cross: nominee

OEM is lawful precisely because it is honest about who owns what. A nominee arrangement is the opposite: a Thai holds the licence and shares on paper while a foreigner runs and owns the business in substance.

That is a criminal offence under Section 36 of Thailand's Foreign Business Act, exposing both parties to criminal penalties, including fines and imprisonment, plus a court-ordered unwinding of the arrangement. The side agreements meant to protect the foreigner become the evidence of the offence.

The tell is simple. In OEM, the Thai producer is genuinely your supplier and keeps real control of its licensed business. In a nominee dressed up as a manufacturing deal, the paperwork quietly hands you control of the Thai entity.

If an offer does that, it is not OEM — walk away. Our note on lawful JV and BOI versus illegal nominee sets out the warning in full.

How CannaBless structures it

CannaBless is an export brokerage — not an exporter, and not a promoter of ownership tricks. Licensed Thai farms cultivate and manufacture; we register, document and connect them to licensed importers in our served markets — Switzerland, Germany and France as priorities, plus the United Kingdom, Australia and the Czech Republic.

For an OEM relationship we scope your specification against what a licensed producer can lawfully make, match you to a farm whose DTAM licence stack fits your destination, and build the documentation trail — licence references, GACP alignment, Certificate of Analysis, phytosanitary and batch records — that your importer's compliance team will audit.

That the pathway executes end to end is a matter of public record. The Italian import permit IT-20261155773424 covers 700 kg of Cannabis Sativa L., phytosanitary-certified and GACP-aligned, arriving Genova in June 2026.

The destination-side mechanics behind a shipment like that are covered in our DTAM export framework and German BfArM import pathway briefings.

Talk to us

If your goal is branded medical-cannabis product in a European or Australian market — not a Thai company to run — OEM is likely the lightest lawful route to it.

Start with a short conversation. Tell our export desk your specification and target market, and we will map it to a licensed Thai producer and the documentation your importer needs, before you commit a baht of working capital.

This is not legal advice. Take any structure to Thai counsel before you sign.

Related briefings

Looking to begin a regulated supply conversation? Reach the export desk →